Key result
ACE inhibitors, angiotensin receptor blockers, and angiotensin IV analogs show promise in the treatment of Alzheimer's and Parkinson's diseases by modulating the brain renin-angiotensin system.
Design
Review
Authors
Loading...
Potential neuroprotective role for RAS modulators in AD/PD; hypothesis-generating from animal data, human trials needed.
This review highlights the potential therapeutic role of targeting the brain renin-angiotensin system, particularly using ACE inhibitors, ARBs, and AngIV analogs, for the treatment of Alzheimer's and Parkinson's diseases.
Wright et al. (2013) conducted a review in Alzheimer's disease and Parkinson's disease. Brain renin-angiotensin system modulators was evaluated. ACE inhibitors, angiotensin receptor blockers, and angiotensin IV analogs show promise in the treatment of Alzheimer's and Parkinson's diseases by modulating the brain renin-angiotensin system.
Synapse has enriched one closely related paper. Consider it for comparative context: